Arete Wealth Advisors’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-44,924
| Closed | -$177K | – | 434 |
|
|
2019
Q3 | $177K | Sell |
44,924
-5,000
| -10% | -$19.7K | 0.03% | 386 |
|
|
2019
Q2 | $232K | Sell |
49,924
-3,334
| -6% | -$15.5K | 0.05% | 340 |
|
|
2019
Q1 | $223K | Hold |
53,258
| – | – | 0.05% | 338 |
|
|
2018
Q4 | $183K | Hold |
53,258
| – | – | 0.04% | 339 |
|
|
2018
Q3 | $228K | Sell |
53,258
-8,334
| -14% | -$35.7K | 0.05% | 319 |
|
|
2018
Q2 | $229K | Buy |
61,592
+2,333
| +4% | +$8.67K | 0.05% | 324 |
|
|
2018
Q1 | $249K | Hold |
59,259
| – | – | 0.08% | 269 |
|
|
2017
Q4 | $348K | Sell |
59,259
-3,334
| -5% | -$19.6K | 0.11% | 214 |
|
|
2017
Q3 | $269K | Hold |
62,593
| – | – | 0.11% | 210 |
|
|
2017
Q2 | $239K | Sell |
62,593
-2,500
| -4% | -$9.55K | 0.11% | 206 |
|
|
2017
Q1 | $175K | Hold |
65,093
| – | – | 0.08% | 192 |
|
|
2016
Q4 | $215K | Buy |
+65,093
| New | +$215K | 0.1% | 163 |
|